Royal Bank of Canada’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.5M | Buy |
585,122
+491,910
| +528% | +$23.1M | 0.01% | 1191 |
|
|
2025
Q1 | $4.11M | Buy |
93,212
+33,869
| +57% | +$1.49M | ﹤0.01% | 2157 |
|
|
2024
Q4 | $2.14M | Sell |
59,343
-11,019
| -16% | -$398K | ﹤0.01% | 2620 |
|
|
2024
Q3 | $2.25M | Buy |
70,362
+2,708
| +4% | +$86.7K | ﹤0.01% | 2578 |
|
|
2024
Q2 | $2.55M | Buy |
67,654
+24,626
| +57% | +$928K | ﹤0.01% | 2450 |
|
|
2024
Q1 | $2.12M | Sell |
43,028
-16,832
| -28% | -$829K | ﹤0.01% | 2554 |
|
|
2023
Q4 | $2.19M | Buy |
59,860
+13,214
| +28% | +$482K | ﹤0.01% | 2573 |
|
|
2023
Q3 | $1.08M | Buy |
46,646
+4,659
| +11% | +$108K | ﹤0.01% | 2940 |
|
|
2023
Q2 | $1.1M | Buy |
41,987
+14,310
| +52% | +$375K | ﹤0.01% | 2920 |
|
|
2023
Q1 | $713K | Sell |
27,677
-1,290
| -4% | -$33.2K | ﹤0.01% | 3265 |
|
|
2022
Q4 | $752K | Buy |
28,967
+2,386
| +9% | +$61.9K | ﹤0.01% | 3324 |
|
|
2022
Q3 | $758K | Buy |
26,581
+1,447
| +6% | +$41.3K | ﹤0.01% | 3241 |
|
|
2022
Q2 | $619K | Sell |
25,134
-1,331
| -5% | -$32.8K | ﹤0.01% | 3478 |
|
|
2022
Q1 | $1.49M | Buy |
26,465
+479
| +2% | +$27K | ﹤0.01% | 2902 |
|
|
2021
Q4 | $1.61M | Buy |
25,986
+10,284
| +65% | +$637K | ﹤0.01% | 2906 |
|
|
2021
Q3 | $996K | Buy |
15,702
+12,713
| +425% | +$806K | ﹤0.01% | 3255 |
|
|
2021
Q2 | $247K | Sell |
2,989
-153
| -5% | -$12.6K | ﹤0.01% | 4425 |
|
|
2021
Q1 | $231K | Buy |
3,142
+2,269
| +260% | +$167K | ﹤0.01% | 4362 |
|
|
2020
Q4 | $64K | Buy |
873
+155
| +22% | +$11.4K | ﹤0.01% | 5020 |
|
|
2020
Q3 | $34K | Sell |
718
-30
| -4% | -$1.42K | ﹤0.01% | 5024 |
|
|
2020
Q2 | $31K | Buy |
748
+2
| +0.3% | +$83 | ﹤0.01% | 4947 |
|
|
2020
Q1 | $20K | Buy |
+746
| New | +$20K | ﹤0.01% | 5055 |
|